tiprankstipranks
Hua Medicine Ltd. (HK:2552)
:2552
Want to see HK:2552 full AI Analyst Report?

Compare Hua Medicine (2552) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Hua Medicine
HK$3.29
HK$3.27B
-9.58
50.45%
HUTCHMED (China)
HK$21.18
HK$18.35B
-13.42%
10 Buy
0 Hold
1 Sell
Strong Buy
Livzon Pharmaceutical Group
HK$30.94
HK$30.34B
9.36
5.64%
1 Buy
0 Hold
1 Sell
Hold
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$32.42B
3.24
5.10%
6 Buy
0 Hold
0 Sell
Strong Buy
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.19
HK$16.60B
8.36
7.17%
Hansoh Pharmaceutical Group Company Limited
HK$39.76
HK$226.68B
20.40
50.98%
10 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2552
Hua Medicine
3.37
1.15
51.80%
HK:0013
HUTCHMED (China)
20.78
-2.62
-11.20%
HK:1513
Livzon Pharmaceutical Group
27.36
2.02
7.98%
HK:3320
China Resources Pharmaceutical Group Ltd.
5.15
0.32
6.69%
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
4.78
0.49
11.42%
HK:3692
Hansoh Pharmaceutical Group Company Limited
36.84
12.66
52.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts